Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
The antitumor efficacy of capecitabine maintenance therapy is promising, and the safety profile is manageable in patients with residual nasopharyngeal carcinoma after receiving standard-of-care treatment.
Authors
- Zhuo-Ying Luo (ORCID: https://orcid.org/0000-0003-2220-1850)
- Xing Lv (ORCID: https://orcid.org/0000-0003-3125-6853)
- Liang‐Ru Ke (ORCID: https://orcid.org/0000-0001-7927-9726)
- Lin‐Quan Tang (ORCID: https://orcid.org/0000-0002-9613-7305)
- Han-Ying Huang (ORCID: https://orcid.org/0000-0002-8635-4867)
- Wei‐Xiong Xia (ORCID: https://orcid.org/0000-0002-2828-5963)
- Yue Xia
- Xun Cao (ORCID: https://orcid.org/0000-0003-1617-1501)
- Lujun Han
- Xi Chen (ORCID: https://orcid.org/0000-0002-8259-9509)
- Shan-Shan Guo
- Yingying Huang (ORCID: https://orcid.org/0000-0003-4837-731X)
- Jiayu Zhou (ORCID: https://orcid.org/0000-0001-7164-0943)
- Xiang Guo
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-4132
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province